CIK 0000899923
- Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870494517
- Phone
- +1 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 23,923 shares (grant or award)
- 4 Open-market sale Chief Operating Officer sold 2,804 shares at $13.78 ($38,630)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award E.V.P., General Counsel acquired 6,541 shares (grant or award)
- 4 Grant or award President, MGL acquired 7,646 shares (grant or award)
- 4 Grant or award President Assurex Health Inc. acquired 7,467 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 10,068 shares (grant or award)
- 4 Grant or award President, MWH acquired 11,525 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 13,787 shares (grant or award)
- 4 Grant or award President and CEO acquired 298,954 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 25,041 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 5 Insider Annual Insider Trading Report
- 4 Grant or award Director acquired 20,562 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Financial Officer acquired 100,000 shares (grant or award)
- 4 Open-market sale President, MGL sold 4,354 shares at $19.73 ($85,915)
- 4 Open-market sale President, MWH sold 7,273 shares at $30.00 ($218,190)
Page 22 of 65 · 1,294 filings